Margaret Friedman v. Montefiore

NOT RECOMMENDED FOR PUBLICATION

File Name: 23a0320n.06

No. 22-3703

UNITED STATES COURT OF APPEALS

FOR THE SIXTH CIRCUIT FILED

Jul 13, 2023

DEBORAH S. HUNT, Clerk

)

MARGARET FRIEDMAN,

)

Plaintiff-Appellee, ) ON APPEAL FROM THE

) UNITED STATES DISTRICT

v. ) COURT FOR THE NORTHERN

) DISTRICT OF OHIO

MONTEFIORE, et al., )

Defendants-Appellants. )

OPINION

)

Before: CLAY, KETHLEDGE, and LARSEN, Circuit Judges.

CLAY, Circuit Judge. Plaintiff Margaret Friedman’s mother died of COVID-19 while

living at the Montefiore nursing home in Beachwood, Ohio. Friedman sued Montefiore and parties

that own and operate it in Ohio state court, asserting negligence and related state-law claims.

Defendants removed the action to the federal district court, but the district court remanded the case

to state court. Montefiore appeals that order, arguing: (1) that Friedman’s claims are completely

preempted by the Public Readiness and Emergency Preparedness Act, 42 U.S.C. §§ 247d-6d(d),

247d-6e (the “PREP Act”); and (2) that the case is removable under the federal officer removal

statute, 28 U.S.C. § 1442(a)(1). For the reasons set forth below, we AFFIRM.

I. BACKGROUND

A. Factual Background

The following factual summary is based upon the allegations in Friedman’s complaint. See

Hudak v. Elmcroft of Sagamore Hills, 58 F.4th 845, 850 (6th Cir. 2023) (providing factual

summary “[a]s alleged in the complaint”).

No. 22-3703, Friedman v. Montefiore, et al.

Friedman’s mother, Mary L. Friedman (“Mary”), moved to Montefiore on February 24,

2020. She lived there until she died from COVID-19 on November 30, 2020. Defendant

Montefiore is a nursing home located in Beachwood, Ohio. Defendants Montefiore Foundation,

Montefiore Home, Montefiore Housing Corporation, and Menorah Park Foundation all own or

operate Montefiore. Defendant Ariel Hyman worked at Montefiore as an administrator while

Mary lived there. For clarity, the Court refers to Defendants collectively as Montefiore.

Friedman alleges that Mary died as a direct result of Montefiore’s negligence. Her

allegations fall into three general categories. First, she alleges that Montefiore “acted with reckless

disregard” with respect to COVID-19 “quarantine [and] containment procedures,” and that Mary

contracted COVID-19 “as a direct result” of Montefiore’s negligence. Compl., R. 1-1, Page ID

#10. Specifically, she alleges that Montefiore (1) failed to “follow basic infection prevention

procedures such as washing hands and wearing masks,” (2) failed to screen and quarantine new

residents for COVID-19, and (3) “forced employees [with COVID-19 symptoms] to work.” Id. at

Page ID #10–11. The second category concerns allegations that Montefiore “negligently,

recklessly, and with malicious intent conduct[ed] improper testing and falsif[ied] tests[, and]

intentionally hid the fact that other” Montefiore residents had contracted COVID-19. Id. In

making those allegations, Friedman points to “the well published and admitted false testing by

Defendants.” Id. On appeal, Friedman avers that those allegations “refer[] to the highly publicized

results of an Ohio Department of Health (ODH) investigation concerning an October 2020

COVID-19 outbreak at the facility.” Appellee Br. at 3–4. The final category involves the care

Montefiore provided once Mary contracted COVID-19. On that front, Friedman alleges that when

Mary “exhibited signs and symptoms requiring emergency hospitalization and treatment . . .

-2-

No. 22-3703, Friedman v. Montefiore, et al.

Defendants failed to provide emergency hospitalization and treatment, referral to a doctor[,] and

oxygen.” Compl., R. 1-1, Page ID #10.

B. Procedural History

Friedman commenced this action “for medical malpractice and/or nursing home neglect

and wrongful death” by filing her complaint in the Court of Common Pleas for Cuyahoga County,

Ohio on October 27, 2021. Montefiore removed the case to the federal district court the next week.

In the notice of removal, Montefiore asserted that the case was removable under 28 U.S.C.

§§ 1441(a) and 1331. Specifically, Montefiore contended that the PREP Act completely

preempted Friedman’s state law claims. The next month, Montefiore filed an amended notice of

removal that invoked the federal officer removal statute, 28 U.S.C. § 1442(a)(1), as another basis

for removal. Montefiore asserted that the federal-officer removal statute applied because it was

“acting under federal officers and/or agencies.” Am. Notice of Removal, R. 12, Page ID #59.

Friedman filed a motion to remand the case to state court, which the district court granted.

In granting the motion to remand, the district observed that Friedman “appears [in her complaint]

to be raising state law claims for medical malpractice, nursing home neglect, survivorship, and

wrongful death.” Order of Remand, R. 19, Page ID #243. The district court then observed that

“the ‘well-pleaded complaint rule’ . . . makes the plaintiff the master of her claims, and she may

avoid federal jurisdiction by exclusive reliance on state law.” Id. at Page ID #246 (citing

Caterpillar Inc. v. Williams, 482 U.S. 386, 392 (1987)). The district court ultimately rejected both

of Montefiore’s bases for removal, holding that the PREP Act does not completely preempt

Friedman’s claims and that the federal officer removal statute does not apply. Montefiore’s timely

appeal followed.

-3-

No. 22-3703, Friedman v. Montefiore, et al.

II. DISCUSSION

A. Standard of Review

The Court reviews de novo a “district court’s determination that it lacked subject-matter

jurisdiction and its consequent decision to issue a remand order.” Hudak, 58 F.4th at 851 (quoting

Mays v. City of Flint, 871 F.3d 437, 442 (6th Cir. 2017)). The “party requesting a federal forum . . .

bears the burden of establishing federal jurisdiction.” Id. at 852 (citing McNutt v. Gen. Motors

Acceptance Corp. of Ind., 298 U.S. 178, 189 (1936)).

B. Analysis

Montefiore contends that removal was proper because (1) the PREP Act completely

preempts Friedman’s claims, and (2) the federal officer removal statute applies. The Court

addresses each argument in turn.

1. Complete Preemption

“Only state-court actions that originally could have been filed in federal court may be

removed to federal court by the defendant.” Caterpillar Inc., 482 U.S. at 392. Where there is not

diversity of citizenship, “federal-question jurisdiction is required” to remove a case. Id. To

determine whether federal-question jurisdiction exists, courts apply “the ‘well-pleaded complaint

rule,’ which provides that federal jurisdiction exists only when a federal question is presented on

the face of the plaintiff’s properly pleaded complaint.” Id. (citing Gully v. First Nat’l Bank, 299

U.S. 109, 112–13 (1936)). The well-pleaded complaint rule “makes the plaintiff the master of the

claim; he or she may avoid federal jurisdiction by exclusive reliance on state law.” Id.

Preemption generally serves as a defense, rather than a basis for removal. Id. However,

where complete preemption exists, removal is proper. Id. Complete preemption exists where “the

pre-emptive force of a statute is so ‘extraordinary’ that it ‘converts an ordinary state common-law

-4-

No. 22-3703, Friedman v. Montefiore, et al.

complaint into one stating a federal claim for purposes of the well-pleaded complaint rule.” Id. at

393 (quoting Metro. Life Ins. Co. v. Taylor, 481 U.S. 58, 65 (1987)). Complete preemption is so

rare that “[t]he Supreme Court has found only three provisions of federal law to be completely

preemptive: § 301 of the Labor Management Relations Act (‘LMRA’), § 502(a)(1)(B) of the

Employee Retirement Income Security Act (‘ERISA’), and §§ 85 and 86 of the National Bank

Act.” Hudak, 58 F.4th at 852 (citing AmSouth Bank v. Dale, 386 F.3d 763, 776 (6th Cir. 2004)).

The Supreme Court found that those provisions were completely preemptive because they

“provided the exclusive cause of action for the claim asserted and also set forth procedures and

remedies governing that cause of action.” Id. at 852–53 (quoting Roddy v. Grand Trunk W. R.R.

Inc., 395 F.3d 318, 323 (6th Cir. 2005)). Where complete preemption does exist, “a federal statute

will completely preempt only those state-law claims that fall within the scope of the federal cause

of action.” Id. at 853 (citing cases).

a. The PREP Act and the 2020 Declaration

“Congress enacted the PREP Act in 2005 ‘[t]o encourage the expeditious development and

deployment of medical countermeasures during a public health emergency’ by allowing the

[Health and Human Services, or HHS] Secretary ‘to limit legal liability for losses relating to the

administration of medical countermeasures such as diagnostics, treatments, and vaccines.’” Id. at

849 (alterations in original) (quoting Cannon v. Watermark Ret. Cmtys., Inc., 45 F.4th 137, 139

(D.C. Cir. 2022)). To fulfill that purpose, the PREP Act “grants immunity from federal and state

liability to ‘covered person[s] . . . with respect to all claims for loss caused by, arising out of,

relating to, or resulting from the administration to or the use by an individual of a covered

countermeasure’ if the HHS Secretary has issued a declaration under the Act ‘with respect to such

countermeasure.’” Id. (alterations in original) (quoting 42 U.S.C. § 247d-6d(a)(1)). However,

-5-

No. 22-3703, Friedman v. Montefiore, et al.

Congress limited such immunity to claims that have “a causal relationship with the administration

to or use by an individual of a covered countermeasure.” 42 U.S.C. § 247d-6d(a)(1)(B).

Additionally, the PREP Act “ensures that its grant of immunity does not foreclose all possible

relief for harms caused by the administration or use of covered countermeasures by creating a

‘Covered Countermeasure Process Fund’ and a corresponding administrative compensation

scheme.” Hudak, 58 F.4th at 849 (quoting 42 U.S.C. § 247d-6e(a)).

The PREP Act also includes an exception to its grant of immunity by providing “an

exclusive Federal cause of action against a covered person for death or serious physical injury

proximately caused by willful misconduct.” 42 U.S.C. § 247d-6d(d)(1). For the purposes of that

exception, “willful misconduct” is “an act or omission that is taken (i) intentionally to achieve a

wrongful purpose; (ii) knowingly without legal or factual justification; and (iii) in disregard of a

known or obvious risk that is so great as to make it highly probable that the harm will outweigh

the benefit.” Id. at § 247d-6d(c)(1)(A). Congress stipulated that willful misconduct “shall be

construed as establishing a standard for liability that is more stringent than a standard of negligence

in any form or recklessness.” Id. at § 247d-6d(c)(1)(B). “Lastly, the Act requires all claims

asserted under it to be brought before a three-judge panel in the District Court for the District of

Columbia and to meet certain special pleading standards.” Hudak, 58 F.4th at 850 (citing 42

U.S.C. § 247d-6d(e)(1)–(9)).

In March 2020, the HHS Secretary issued its Declaration Under the [PREP] Act for

Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (the “Declaration”). In that

Declaration, the Secretary declared that COVID-19 was a public health emergency under the PREP

Act. Id. at 15198. In response to that emergency, the Secretary recommended “the manufacture,

testing, development, distribution, administration, and use of the Covered Countermeasures.” Id.

-6-

No. 22-3703, Friedman v. Montefiore, et al.

at 15201. “Covered Countermeasures” included “any antiviral, any other drug, any biologic, any

diagnostic, any other device, or any vaccine, used to treat, diagnose, cure, prevent, or mitigate

COVID-19 . . . or any device used in the administration of any such product, and all components

and constituent materials of any such product.” Id. at 15202. The Secretary also provided that

those “Covered Countermeasures must be ‘qualified pandemic or epidemic products,’ or ‘security

countermeasures,’ or drugs, biological products, or devices authorized for investigational or

emergency use.”1 Id.

b. The PREP Act and Complete Preemption

Hudak is this Court’s first published case concerning the PREP Act’s preemptive effect.

Accordingly, it controls. See Darrah v. City of Oak Park, 255 F.3d 301, 309 (6th Cir. 2001). In

Hudak, this Court recognized that “there is no question that the PREP Act has significant ‘pre-

emptive force.’” Hudak, 58 F.4th at 853 (quoting Caterpillar, 482 U.S. at 393). However, the

Court held that where a plaintiff “do[es] not allege willful misconduct related to the administration

or use of covered COVID-19 countermeasures,” the PREP Act does not completely preempt state

law claims. Id. Every other circuit to have considered the issue has reached the same conclusion.

See, e.g., Solomon v. St. Joseph Hosp., 62 F.4th 54, 60–62 (2d Cir. 2023); Maglioli v. All. HC

Holdings LLC, 16 F.4th 393, 406–13 (3d Cir. 2021); Mitchell v. Advanced HCS, L.L.C., 28 F.4th

580, 584–88 (5th Cir. 2022); Manyweather v. Woodlawn Manor, Inc., 40 F.4th 237, 242–46 (5th

Cir. 2022); Martin v. Petersen Health Operations, LLC, 37 F.4th 1210, 1213–14 (7th Cir. 2022);

Saldana v. Glenhaven Healthcare LLC, 27 F.4th 679, 687–88 (9th Cir. 2022).

1

Since first issuing the Declaration, the Secretary has amended it eleven times, most

recently on May 12, 2023. See Eleventh Amendment to Declaration Under the [PREP] Act for

Medical Countermeasures Against COVID-19, 88 Fed. Reg. 30769.

-7-

No. 22-3703, Friedman v. Montefiore, et al.

Hudak held that the PREP Act’s “general immunity provision,” i.e., 42 U.S.C. § 247d-

6d(a)(1), “reflects ‘an ordinary rule of preemption, a defense to liability under state law.’” Hudak,

58 F.4th at 853–54 (quoting Martin, 37 F.4th at 1213). Thus, § 247d-6d(a)(1) “does not create a

federal cause of action that completely preempts covered state-law claims.” Id. Instead, it “might

or might not provide [Montefiore] with a viable defense in state court.” Id. In other words, unless

a plaintiff states a claim under § 247d-6d(d)(1), complete preemption is disqualified as a basis for

removal. Id.

Hudak did not resolve whether § 247d-6d(d)(1) is completely preemptive. See id. at 854.

Section 247d-6d(d)(1) establishes “an exclusive Federal cause of action against a covered person

for death or serious physical injury proximately caused by willful misconduct . . . by such covered

person.” 42 U.S.C. § 247d-6d(d)(1). “Unlike the general immunity provision, it is debatable

whether § 247d-6d(d)(1) completely preempts certain state-law claims.” Hudak, 58 F.4th at 854.

The Court in Hudak observed that “[o]ther federal courts of appeals have not reached a consensus

as to whether the PREP Act completely preempts state-law claims that fall within the scope of

§ 247d-6d(d)(1)’s federal cause of action,” and “declin[ed] to decide whether § 247d-6d(e)(1) is

completely preemptive.” Id. The Court reasoned that it need not make such a determination

because the plaintiff’s claims did not fall within the scope of the federal cause of action. Id.

i. Determining Whether Friedman’s Claims Fall Under § 247d-6d(d)(1)

The PREP Act establishes an exclusive federal cause of action for willful misconduct only.

Id. As the Third Circuit observed, “[w]illful misconduct is a separate cause of action from

negligence . . . . Congress could have created a cause of action for negligence or general tort

liability. It did not. Just as intentional torts, strict liability, and negligence are independent causes

-8-

No. 22-3703, Friedman v. Montefiore, et al.

of action, so too willful misconduct under the PREP Act is an independent cause of action.”

Maglioli, 16 F.4th at 411 (citing Restatement (Second) of Torts § 519 cmt. d (Am. L. Inst. 1977)).

A plaintiff does not allege willful misconduct under § 247d-6d(d)(1) unless the pleading

contains: (1) allegations of willful misconduct related to the administration or use of covered

COVID-19 countermeasures; and (2) allegations of “a ‘causal relationship with the administration

to or use by an individual of a covered countermeasure[.]’” Hudak, 58 F.4th at 853–55 (alteration

in original) (quoting 42 U.S.C. § 247d-6d(a)(2)(B)). Friedman’s complaint contains neither.

First, Friedman does not allege willful misconduct as defined in the PREP Act. To allege

willful misconduct under the PREP Act, a plaintiff must “plead with particularity,” 42 U.S.C.

§ 247d-6d(e)(3)(A), that defendants took actions “(i) intentionally to achieve a wrongful purpose;

(ii) knowingly without legal or factual justification; and (iii) in disregard of a known or obvious

risk that is so great as to make it highly probable that the harm will outweigh the benefit,” id. §

247d-6d(c)(1)(A) (emphasis added). Friedman’s complaint does not include all three of those

elements. Dispositively, Friedman never alleges with particularity that Montefiore acted

“intentionally to achieve a wrongful purpose.” Id. The absence of such an allegation alone is

sufficient to defeat Montefiore’s preemption argument.2 See Hudak, 58 F.4th at 854.

Second, Friedman’s complaint does not satisfy the PREP Act’s causality requirement. To

bring a willful misconduct claim under the PREP Act, a plaintiff must also allege “a causal

relationship with the administration to or use by an individual of a covered countermeasure.” Id.

2

The district court made this point in its order remanding the case to state court.

Montefiore’s opening brief is silent on the matter. In its reply brief, Montefiore suggests in a

parenthetical that Friedman’s allegations concerning test-falsification satisfy this element.

However, alleging that Montefiore falsified tests is not enough to plead with particularity that

Montefiore acted “intentionally to achieve a wrongful purpose.” Id. § 247d-6d(c)(1)(A); see

Hudak, 58 F.4th at 853–55.

-9-

No. 22-3703, Friedman v. Montefiore, et al.

§ 247d-6d(a)(2)(B). A plaintiff must also “plead with particularity . . . each act or omission, by

each covered person sued, that is alleged to constitute willful misconduct relating to the covered

countermeasure administered to or used by the person on whose behalf the complaint was filed.”

Id. § 247d-6d(e)(3)(A).

In her complaint, Friedman alleges that Montefiore:

had been negligently, recklessly, and with malicious intent improperly

implementing SARS-COV2 and/or any other form of covid-19 or covid-19 related

illness prevention measures. Moreover, they were negligently, recklessly, and with

malicious intent conducting improper testing and falsifying tests. They

intentionally hid the fact that other patients and/or residents of Montefiore had

SARS-COV2 and/or any other form of covid-19 or covid-19 related illness. As a

result, Decedent and others were unnecessarily exposed, without their knowledge,

to SARS-COV2 and/or any other form of covid-19 or covid-19 related illness.

Compl., R. 1-1, Page ID #11 (emphasis added). Montefiore wrongly contends that this is sufficient

to meet § 247d-6d(a)(2)(B)’s causality requirement. Although it is true that Friedman alleges that

Montefiore’s test falsification led her to be exposed to COVID-19, at no point does she plead with

particularity that it led to her contracting COVID-19. Thus, as in Hudak, “[n]owhere in the

complaint does [Friedman] allege that ‘the administration to or use by [decedent] of a’ COVID-19

countermeasure caused [her] illness or death.” Hudak, 58 F.4th at 856 (quoting 42 U.S.C. § 247d-

6d(a)(2)(B)).

In sum, Friedman never alleges with particularity that Montefiore acted “intentionally to

achieve a wrongful purpose,” as § 247d-6d(c)(1)(A) requires. Additionally, she does not plead

with particularity that Mary’s death had a “a causal relationship with the administration to or use

by an individual of a covered countermeasure.” Id. § 247d-6d(a)(2)(B). Accordingly, “[b]ecause

[Friedman] does not allege willful misconduct within the meaning of the PREP Act, the Act does

not provide her with a federal cause of action and her claims are not completely preempted.”

- 10 -

No. 22-3703, Friedman v. Montefiore, et al.

Hudak, 58 F.4th at 855. Because Friedman does not state a claim under § 247d-6d(e)(1), the Court

need not decide whether that provision is completely preemptive. See id. at 854.

2. Federal Officer Removal Statute

Montefiore also asserts that Friedman’s claims are “removable because Defendants were

specifically ‘acting under’ federal officers and federal authority in administering COVID-19

diagnostic tests—a ‘covered countermeasure’ designated as serving a public health function under

the PREP Act.” Appellants’ Br. at 38.

A defendant may remove a state court action to federal court if the action is brought against:

[t]he United States or any agency thereof or any officer (or any person acting under

that officer) of the United States or of any agency thereof, in an official or individual

capacity, for or relating to any act under color of such office or on account of any

right, title or authority claimed under any Act of Congress for the apprehension or

punishment of criminals or the collection of the revenue.

28 U.S.C. § 1442(a)(1). “Federal courts have subject-matter jurisdiction over claims that are

properly removed under § 1442(a)(1).” Hudak, 58 F.4th at 858 (citing Mesa v. California, 489

U.S. 121, 136 (1989)). In cases where the defendants are not federal officers, the removing

defendants “must satisfy three requirements in order to invoke the federal-officer removal statute:

(1) the defendants must establish that they acted under a federal officer, (2) those actions must

have been performed under color of federal office, and (3) the defendants must raise a colorable

federal defense.” Mays v. City of Flint, 871 F.3d 437, 442–43 (6th Cir. 2017) (citing Bennett v.

MIS Corp., 607 F.3d 1076, 1085 (6th Cir. 2010)).

To demonstrate that it was acting under a federal officer, Montefiore “must show that it

was ‘in a relationship with the federal government where the government [was] functioning as the

defendant’s superior.’” Hudak, 58 F.4th at 858 (quoting Mays, 871 F.3d at 444). Such a

“relationship typically involves subjection, guidance, or control.” Watson v. Philip Morris

- 11 -

No. 22-3703, Friedman v. Montefiore, et al.

Companies, Inc., 551 U.S. 142, 151 (2007) (quotation omitted). “In addition, precedent and

statutory purpose make clear that the private person’s ‘acting under’ must involve an effort to

assist, or to help carry out, the duties or tasks of the federal superior.” Id. at 152. Importantly,

“the help or assistance necessary to bring a private person within the scope of the statute does not

include simply complying with the law.” Id.

In Hudak, the defendants made the same argument that Montefiore makes in this appeal.

The Court in Hudak expressly rebuffed the defendants’ arguments that they were “acting under” a

federal officer because they had to comply with federal mandates, and because they “performed a

governmental function by helping to contain the spread of the COVID-19 virus.” Hudak, 58 F.4th

at 859. Montefiore’s arguments fail for the same reason: Montefiore “did not have an agreement

with the federal government, did not produce a good or perform a service on behalf of the

government, and has not shown that the federal government exercised control over its operations

to such a degree that the government acted as [Montefiore’s] superior.” Id. at 859–60. The Court’s

analysis in Hudak applies verbatim to the instant appeal. Put simply, in passing the PREP Act,

“Congress did not deputize all of these private-sector workers as federal officers.” Maglioli, 16

F.4th at 406. A party cannot invoke the federal officer removal statute simply because it complied

with federal law. Watson, 551 U.S. at 152.

CONCLUSION

For the reasons stated above, the district court’s order remanding this case to state court is

AFFIRMED.

- 12 -